ILD Risk Elevated in RA, PsA After Starting DMARDs ILD Risk Elevated in RA, PsA After Starting DMARDs

The risk for interstitial lung disease in patients with PsA during the first 5 years was five times higher than for the general population, and the risk was not modified by methotrexate use.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news